The primary outcome measure is adverse event monitoring from baseline to week 52
You can shift your weekly injection by a day or two without losing effectiveness, making it easier to maintain treatment continuity during travel, shift work, or major schedule changes
Physiologically, the body returns to its baseline state once GLP-1 receptor stimulation ceases
doi: 10.3389/fmed.2026.1763185 Received 08 December 2025 Revised 20 January 2026 Accepted 26 January 2026 Published 12 February 2026 Volume 13 - 2026 Edited by Jianbin Zhang, Dalian Medical University, China Reviewed by Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece Feng Zhang, Nanjing University of Chinese Medicine, China Updates Copyright 2026 Lu and Yang
Excessive fat can also trigger nausea